Exact Mass: 309.016319
Exact Mass Matches: 309.016319
Found 148 metabolites which its exact mass value is equals to given mass value 309.016319,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lamivudine-monophosphate
C8H12N3O6PS (309.01844220000004)
Lamivudine-monophosphate is a metabolite of lamivudine. Lamivudine (2,3-dideoxy-3-thiacytidine, commonly called 3TC) is a potent nucleoside analog reverse transcriptase inhibitor (nRTI). It is marketed by GlaxoSmithKline with the brand names Zeffix, Heptovir, Epivir, and Epivir-HBV. Lamivudine has been used for treatment of chronic hepatitis B at a lower dose than for treatment of HIV. It improves the seroconversion of e-antigen positive hepatitis B and also improves histology staging of the liver. (Wikipedia)
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid
2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid is a metabolite of mefloquine. Mefloquine hydrochloride (also known as Lariam or Mefaquin) is an orally administered medication used in the prevention and treatment of malaria. Mefloquine was developed in the 1970s at the United States Department of Defenses Walter Reed Army Institute of Research as a synthetic analogue of quinine. The brand name drug, Lariam, is manufactured by the Swiss company Hoffmann–La Roche. In August 2009, Roche stopped marketing Lariam in the United States. (Wikipedia)
Hydroxylumiracoxib
C15H13ClFNO3 (309.0567950000001)
Hydroxylumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)
3-oxobrimonidine
3-oxobrimonidine is a metabolite of brimonidine. Brimonidine (bri-MOE-ni-deen, brand names Alphagan and Alphagan-P) is a drug used to treat open-angle glaucoma or ocular hypertension. It acts via decreasing synthesis of aqueous humor, and increasing the amount that drains from the eye through uveoscleral outflow. As a treatment for glaucoma, it is usually given in eyedrop form. (Wikipedia)
methyl 1-(4-chlorophenyl)-5-(2-methoxy-2-oxoethyl)-1H-1,2,3-triazole-4-carboxylate
2-Hydroxy-1-methoxy-4-oxo-4,5-dihydrodibenzo[cd,f]indole-3-carboxylic acid
PRZ_M310
C12H14Cl3NO2 (309.00900740000003)
CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2015
2,8-BIS(TRIFLUROMETHYL)-4-QUINOLINCARBOXYLIC ACID
2-(2-Benzenesulfonamido-5-pyrimidinyloxy)acetic acid
C12H11N3O5S (309.04193960000003)
p-nitrophenyl 2-(furfurylsulfinyl)acetic acid
C13H11NO6S (309.03070660000003)
ethyl 6-bromo-8-methyl-4-oxo-1H-quinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
7-CHLORO-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER
C15H13ClFNO3 (309.0567950000001)
5-(CHLOROMETHYL)-2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOLE
3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine
METHYL 3-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-2-CARBOXYLATE
2-chloro-10-(3-chloropropyl)-10H-phenothiazine
C15H13Cl2NS (309.01457180000006)
TERT-BUTYL 3-BROMO-7-METHYL-1H-INDOLE-1-CARBOXYLATE
4-BROMO-N-(FURAN-2-YLMETHYL)-3-METHOXYBENZAMIDE
C13H12BrNO3 (309.00005020000003)
Ethyl1-(5-bromopyridin-2-yl)-5-methylpyrazole-4-carboxylate
5-Bromo-1-(4-methoxybenzyl)-1H-pyrrole-2-carboxylic acid
C13H12BrNO3 (309.00005020000003)
2,5-Cyclohexadien-1-one,4-[[4-(acetyloxy)phenyl]imino]-2,6-dichloro-
Ethanone,2-chloro-1-(2-chloro-10H-phenothiazin-10-yl)-
ethyl 4-bromo-6-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
3-(3-chlorophenyl)-4-cyano-5-methylsulfanylthiophene-2-carboxylic acid
3-(4-CHLOROPHENYL)-4-CYANO-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
4-(2,4-difluorophenoxy)-n-hydroxy-3-nitrobenzenecarboximidamide
ETHYL5-AMINO-1-(4-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
3-(Boc-amino)-6,6-dichlorobicyclo[3.1.0]hexane-3-carboxylic Acid
METHYL 2-([3-(CHLOROMETHYL)BENZOYL]AMINO)THIOPHENE-3-CARBOXYLATE
METHYL 3-AMINO-4-(ISOPROPYLSULFONYL)-5-(METHYLTHIO)THIOPHENE- 2-CARBOXYLATE
[2-(3-bromo-phenyl)-ethyl]-(4-chloro-phenyl)-amine
C14H13BrClN (308.9919828000001)
ETHYL 5-AMINO-1-(2-BROMOPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE
4-Bromo-1-(tert-butyldimethylsilyl)indole
C14H20BrNSi (309.05483000000004)
6-Bromo-1-(tert-butyldimethylsilyl)indole
C14H20BrNSi (309.05483000000004)
TERT-BUTYL 5-(BROMOMETHYL)-1H-INDOLE-1-CARBOXYLATE
2-[2-(2-amino-1,3-thiazol-4-yl)ethyl]isoindole-1,3-dione,hydrochloride
tert-butyl 4-(bromomethyl)-1H-indole-1-carboxylate
2-[2-(1-bromonaphthalen-2-yl)oxyethylamino]ethanol
3-Chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-ol 5,5-dioxide
ethyl 4-bromo-8-methoxyquinoline-3-carboxylate
C13H12BrNO3 (309.00005020000003)
4-ISOXAZOLECARBOXYLIC ACID, 5-(4-BROMOPHENYL)-3-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
TERT-BUTYL 7-(BROMOMETHYL)-1H-INDOLE-1-CARBOXYLATE
Ethyl 3-bromo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate hydrochloride
2-(4-chloro-2-methylphenoxy)-N-(2-chlorophenyl)acetamide
5-bromo-N-cyclopentyl-2-(trifluoromethyl)pyrimidin-4-amine
4-(4-Aminoanilino)-3-nitrobenzenesulphonic acid
C12H11N3O5S (309.04193960000003)
4-[[(4-CHLORO-2,5-DIMETHYLPHENYL)SULFONYL]METHYL]ANILINE
4-bromo-N-(tert-butyl)-2-fluorobenzenesulfonamide
C10H13BrFNO2S (308.98343500000004)
methyl (2S)-2-(2-chlorophenyl)-2-(2-thiophen-2-ylethylamino)acetate
5-bromo-n-(2-hydroxyethyl)-2-methoxybenzenesulfonamide
2-(5-bromo-4-oxopentyl)isoindole-1,3-dione
C13H12BrNO3 (309.00005020000003)
4-[(4-CHLOROPHENYL)SULFANYL]-3-NITROBENZENECARBOXYLIC ACID
C13H8ClNO4S (308.98625580000004)
5-bromo-1-(tert-butyldimethylsilyl)-1h-indole
C14H20BrNSi (309.05483000000004)
2-(4-Aminoanilino)-5-nitrobenzenesulphonic acid
C12H11N3O5S (309.04193960000003)
4-ISOXAZOLECARBOXYLIC ACID, 3-(4-BROMOPHENYL)-5-METHYL-, ETHYL ESTER
C13H12BrNO3 (309.00005020000003)
Brofaromine
D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Anagrelide hydrochloride monohydrate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent
5-Hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 5-hydroxylation followed by oxidation.
N-(5-chloro-2-pyridinyl)-2-(3,5-dimethyl-4-nitro-1-pyrazolyl)acetamide
C12H12ClN5O3 (309.06286320000004)
6-Amino-5-[(4-chlorophenyl)sulfonyl]-2-hydroxynicotinonitrile
C12H8ClN3O3S (308.99748880000004)
1-Methyl-3-trifluoromethyl-1H-thieno[2,3-C]pyrazole-5-carboxylic acid (2-mercapto-ethyl)-amide
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]formamide
C12H14Cl3NO2 (309.00900740000003)
(2R)-2-amino-3-(6-chloro-2-phenylpyrimidin-4-yl)sulfanylpropanoic acid
(2R)-2-amino-3-(1H-indol-3-ylmethylcarbamothioylsulfanyl)propanoic acid
N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide
2-[(2-pyridinylthio)methyl]-1H-benzofuro[3,2-d]pyrimidin-4-one
4,5-Dimethyl-2-[[oxo(thiophen-2-yl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester
N-[5-(ethoxymethyl)-1,3,4-thiadiazol-2-yl]-2-(phenylthio)acetamide
2-(2-methoxyethylthio)-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzamide
(2Z)-2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)methylidene]-4-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-3-olate
4-hydroxydiclofenac quinone imine
A quinone imine that is a metabolite of diclofenac arising from 4-hydroxylation followed by oxidation.
3-bromo-4-(2-imino-1,3-dihydroimidazol-4-yl)-1h,4h,5h,6h-pyrrolo[2,3-c]azepin-8-ol
aristolactam c ii; 1'-carboxylic acid,o2-de-me
{"Ingredient_id": "HBIN016768","Ingredient_name": "aristolactam c ii; 1'-carboxylic acid,o2-de-me","Alias": "NA","Ingredient_formula": "C17H11NO5","Ingredient_Smile": "NA","Ingredient_weight": "309.27","OB_score": "NA","CAS_id": "106283-33-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6676","PubChem_id": "NA","DrugBank_id": "NA"}
